bpc-157 human studies safety evidence review What is BPC-157? bpc-157 human clinical trials evidence
Description
TB-500 How TB-500 Works TB500 is a synthetic version of thymosin beta-4 (TB-4) a naturally occurring peptide involved in tissue regeneration, angiogenesis, and cell migration
A reference card of the molecular and physical attributes for the peptides in this formulation
No large-scale, randomized placebo-controlled trials have established efficacy or formal indications for BPC-157
Our Story Our Story on Peptides Clinic
Current Evidence Base What 12 Weeks of Data Actually Shows The longest-duration human trial on 5-Amino-1MQ was a 12-week randomised placebo-controlled study conducted at the University of Copenhagen, published in 2024
You get the same professional care you'd receive in a clinical setting, but in the comfort of your own space
